“[Cost-Consequence Analysis of Vedolizumab Initiation Timing Strategies in Crohn’s Disease in Italy]”. 2026. Farmeconomia. Health Economics and Therapeutic Pathways 27 (1). https://doi.org/10.7175/fe.v27i1.1605.